可药性
计算生物学
范围(计算机科学)
药物发现
计算机科学
小分子
模式
化学
生物信息学
纳米技术
药物开发
药品
生物分子
透视图(图形)
治疗方式
生物
分子构象
蛋白质-蛋白质相互作用
作者
Ahmed M. Kamal El-sagheir
出处
期刊:ChemMedChem
[Wiley]
日期:2026-09-29
卷期号:21 (19): e70516-e70516
摘要
The concept of "undruggable" targets has long represented a major limitation in medicinal chemistry, referring to proteins and biomolecules that lack well-defined binding pockets or exhibit highly dynamic conformational behavior. However, advances in structural biology, chemical biology, and computational methodologies are rapidly expanding the scope of tractable therapeutic space. Emerging modalities, including targeted protein degradation, molecular glues, macrocycles, RNA-targeting small molecules, covalent ligands, and artificial intelligence-assisted molecular design, enable pharmacological mechanisms beyond classical occupancy-based inhibition through strategies such as induced proximity, expanded molecular recognition, covalent engagement, and RNA-level regulation. These approaches challenge the traditional binary classification of druggability and support a more context-dependent view of therapeutic accessibility. Despite this progress, significant challenges remain in optimizing pharmacokinetic properties, ensuring selectivity, minimizing toxicity, and achieving robust clinical translation. This editorial provides a mechanistic perspective on how emerging modalities are extending the boundaries of modern drug discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI